BRIEF-Merck says FDA to take extra 3 mos to review sugammadex anesthesia-reversal agent
March 15 (Reuters) - Merck & Co Inc : * Says FDA will take extra 3 months to review sugammadex anesthesia-reversal
agent * Says now expects FDA review of marketing application to be completed in
second half 2013
- Putin dissolves state news agency, tightens grip on Russia media
- North Korea says Kim's powerful uncle dismissed for 'criminal acts'
- Thai PM calls snap election, protesters want power now |
- Record cold, ice grip U.S.; more snow to blanket East
- Protesters fell Lenin statue, tell Ukraine's president 'you're next'